GAMIDA CELL LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0184 USD | +2.22% |
|
+6.36% | -95.54% |
| Apr. 10 | Gamida Cell Ltd.(NasdaqGM:GMDA) dropped from S&P Global BMI Index | CI |
| Apr. 05 | Gamida Cell Ltd.(OTCPK:GMDA.Q) dropped from NASDAQ Composite Index | CI |
Chart calendar Gamida Cell Ltd.
64cdfd812aa2daa.LovOyRab8gBO-OX-yGO10ak4Oqfs0Ovreym-N_wITFs.ZdG_-VjPoEoDgqSUu1fhlvMBcMmunZKlGkb2QYZGNT180aedQ9CidxGaqA~af864903b242bc9f272180c5e35bcba2
Upcoming events on Gamida Cell Ltd.
Past events on Gamida Cell Ltd.
| 2024-03-27 08:30 am | Q4 2023 Earnings Call |
| 2024-03-27 07:00 am | Q4 2023 Earnings Release |
| 2024-02-22 07:45 pm | American Society for Transplantation and Cellular Therapy and CIBMTR Meeting - Abstract No: 313 |
| 2024-02-22 07:45 pm | American Society for Transplantation and Cellular Therapy and CIBMTR Meeting - Abstract No: 255 |
| 2023-11-28 11:00 am | Piper Sandler Healthcare Conference |
| 2023-11-14 08:30 am | Q3 2023 Earnings Call |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 336 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 401 |
| 2023-10-11 07:45 pm | Cell & Gene Meeting on the Mesa Conference |
| 2023-10-11 06:15 pm | Cell & Gene Meeting on the Mesa Conference - Panel |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 08:30 am | Q2 2023 Earnings Call |
| 2023-08-14 07:00 am | Q2 2023 Earnings Release |
| 2023-06-29 08:00 am | Investor Day |
| 2023-06-08 09:30 am | Jefferies Global Healthcare Conference |
| 2023-06-02 03:15 am | International Society for Cell and Gene Therapy Meeting - Abstract Number: 36 |
| 2023-06-01 12:00 pm | International Society for Cell and Gene Therapy Meeting - Abstract Number: 1225 |
| 2023-05-19 10:00 am | Extraordinary Shareholders Meeting |
| 2023-05-15 04:30 pm | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,78 1,73 3.15% | 16,8 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -48,2 -45,6 -5.7% | -62,3 -57,4 -8.62% | -87,2 -89,0 2.09% | -75,0 -72,3 -3.78% | -73,0 -73,7 0.95% | -66,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -34,4 -32,6 -5.44% | -72,7 -56,7 -28.26% | -89,8 -83,8 -7.15% | -79,4 -74,7 -6.32% | -63,0 -83,1 24.23% | -70,1 |
|
Net income Million USD | Released Forecast Spread | -34,4 -32,7 -5.17% | -72,7 -56,9 -27.67% | -89,8 -83,0 -8.22% | -79,4 -74,8 -6.07% | -63,0 -80,6 21.87% | -71,6 |
|
EPS USD | Released Forecast Spread | -1,17 -1,10 -6.69% | -1,66 -1,31 -26.91% | -1,52 -1,42 -7.04% | -1,24 -1,19 -4.55% | -0,57 -0,77 25.97% | -0,57 |
| Announcement Date | 25/02/20 | 09/03/21 | 15/03/22 | 27/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,17 - | 0,67 2,37 -71.61% | 1,11 1,06 4.69% | 4,44 | 4,63 | 5,01 | 5,21 |
|
EBIT Million USD | Released Forecast Spread | -22,3 -24,2 7.72% | -19,3 -19,8 2.44% | -18,0 -18,0 -0.41% | -17,1 -17,8 4.14% | -20,6 -17,8 -15.42% | -19,6 -20,8 5.77% | -18,8 -18,3 -2.92% | -18,1 -17,0 -6.38% | -16,6 -17,3 4.1% | -16,0 | -16,3 | -17,0 | -16,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,8 -24,4 -26.4% | -20,2 -20,1 -0.47% | -18,6 -17,8 -4.25% | -17,8 -19,0 6.54% | -22,8 -18,1 -25.94% | -21,0 -21,6 2.83% | -31,7 -19,3 -63.88% | -1,52 -16,3 90.7% | -8,84 -18,0 50.78% | -17,0 | -17,3 | -18,0 | -17,8 |
|
Net income Million USD | Released Forecast Spread | -30,8 -24,4 -26.4% | -20,2 -20,1 -0.47% | -18,6 -17,8 -4.25% | -17,8 -18,8 5.43% | -22,8 -18,3 -24.73% | -21,0 -21,6 2.83% | -31,7 -19,3 -63.88% | -1,52 -17,7 91.42% | -8,84 -18,0 50.78% | -17,0 | -17,3 | -18,0 | -17,8 |
|
EPS USD | Released Forecast Spread | -0,52 -0,41 -28.4% | -0,34 -0,34 0% | -0,31 -0,29 -6.16% | -0,29 -0,31 5.23% | -0,29 -0,25 -16% | -0,27 -0,27 -0.93% | -0,31 -0,20 -58.97% | -0,01 -0,17 94.03% | -0,04 -0,15 73.77% | -0,14 | -0,15 | -0,15 | -0,15 |
| Announcement Date | 15/03/22 | 10/05/22 | 15/08/22 | 14/11/22 | 27/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 27/03/24 | - | - | - | - |
More events
Past sector events for Gamida Cell Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GMDA Stock
- Calendar Gamida Cell Ltd.
